sodium thiosulfate has been researched along with Mesothelioma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, MY; Sugarbaker, DJ | 1 |
Cleary, S; Howell, SB; Markman, M; Pfeifle, C | 1 |
Cleary, S; Howell, SB; Markman, M | 2 |
Ehninger, G; Haag, C; Rückle, H; Wilms, K | 1 |
1 review(s) available for sodium thiosulfate and Mesothelioma
Article | Year |
---|---|
Innovative therapies: intraoperative intracavitary chemotherapy.
Topics: Antineoplastic Agents; Cisplatin; Clinical Trials, Phase I as Topic; Humans; Hyperthermia, Induced; Intraoperative Period; Mesothelioma; Pleural Neoplasms; Thiosulfates | 2004 |
4 other study(ies) available for sodium thiosulfate and Mesothelioma
Article | Year |
---|---|
Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Cisplatin; Female; Humans; Injections, Intraperitoneal; Male; Mesothelioma; Middle Aged; Nausea; Pleura; Punctures; Thiosulfates | 1986 |
Hypomagnesemia following high-dose intracavitary cisplatin with systemically administered sodium thiosulfate.
Topics: Adult; Aged; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Magnesium; Male; Mesothelioma; Middle Aged; Ovarian Neoplasms; Retrospective Studies; Thiosulfates | 1986 |
[Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics].
Topics: Adenocarcinoma; Ascites; Carcinoma; Catheterization; Cisplatin; Female; Humans; Kinetics; Male; Mesothelioma; Middle Aged; Peritoneal Cavity; Peritoneal Neoplasms; Pilot Projects; Thiosulfates; Time Factors | 1985 |
Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection.
Topics: Acute Kidney Injury; Adult; Aged; Cisplatin; Creatinine; Female; Humans; Injections; Injections, Intraperitoneal; Male; Mesothelioma; Middle Aged; Ovarian Neoplasms; Pleura; Thiosulfates | 1985 |